Calumet, Inc. /DE (CLMT)
| Market Cap | 4.95B+208.1% |
| Revenue (ttm) | 4.59B |
| Net Income | -136.80M |
| EPS | -1.55 |
| Shares Out | 87.90M |
| PE Ratio | n/a |
| Forward PE | 89.35 |
| Dividend | n/a |
| Ex-Dividend Date | Jan 29, 2016 |
| Volume | 949,279 |
| Open | 56.25 |
| Previous Close | 56.21 |
| Day's Range | 56.05 - 56.87 |
| 52-Week Range | 17.42 - 59.87 |
| Beta | 0.78 |
| Analysts | none |
| Price Target | 53.40(-5.13%) |
| Earnings Date | Nov 6, 2026 |
Insiders here have filed 7 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About CLMT
Calumet, Inc. manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. It operates through Specialty Products and Solutions; Performance Brands; and Montana/Renewables segments. The Specialty Products and Solutions segment manufactures and markets various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The Montana/Renewables segment processes geographically advantaged renewable feedstocks into renewable diesel, aviation fuel, and renewable naphtha. This segment also engages in the process of Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. The Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. It serves wholesale distributors and retail chains. Calumet, Inc. was founded in 1919 and is headquartered in Indianapolis, Indiana.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$CLMT stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in CLMT holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CLMT's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CLMT Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CLMT Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Reportable segment information | $1.45B | 46.84% |
| PP&E, net | $1.32B | 42.83% |
| Segment Adjusted EBITDA | $178.70M | 5.79% |
| RINs mark-to-market loss | $115.60M | 3.75% |
| Equity-based compensation and other items | $19.50M | 0.63% |
| LCM / LIFO (gain) loss | $4.40M | 0.14% |
| Other | $200.00K | 0.01% |
| Noncontrolling interest adjustments | $200.00K | 0.01% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New CLMT patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CLMT from public contracts
Source: USAspending.gov
CLMT Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CLMT’s recent data — informational, not investment advice